Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics

BACKGROUND: The retinal pigment epithelium (RPE) is implicated in the pathophysiology of many retinal degenerative diseases. This cell layer is also an ideal target for cell-based therapies. Several early phase clinical trials evaluating cell therapy approaches for diseases involving the RPE, such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinkle, John W., Mahmoudzadeh, Raziyeh, Kuriyan, Ajay E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504041/
https://www.ncbi.nlm.nih.gov/pubmed/34635174
http://dx.doi.org/10.1186/s13287-021-02546-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504041/
https://www.ncbi.nlm.nih.gov/pubmed/34635174
http://dx.doi.org/10.1186/s13287-021-02546-9

Ejemplares similares